RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $109,000 | -86.0% | 96,883 | -62.8% | 0.00% | -83.3% |
Q1 2022 | $778,000 | +489.4% | 260,146 | +423.1% | 0.02% | +500.0% |
Q4 2021 | $132,000 | -45.2% | 49,735 | -25.2% | 0.00% | -57.1% |
Q3 2021 | $241,000 | -18.9% | 66,522 | -2.8% | 0.01% | -30.0% |
Q2 2021 | $297,000 | +139.5% | 68,456 | +88.5% | 0.01% | +100.0% |
Q1 2021 | $124,000 | -58.4% | 36,319 | -57.3% | 0.01% | -54.5% |
Q4 2020 | $298,000 | -40.5% | 85,049 | -59.3% | 0.01% | -63.3% |
Q3 2020 | $501,000 | +17.6% | 208,821 | -10.3% | 0.03% | +3.4% |
Q2 2020 | $426,000 | +25.7% | 232,850 | +7.3% | 0.03% | +3.6% |
Q1 2020 | $339,000 | +149.3% | 217,050 | +241.2% | 0.03% | +133.3% |
Q4 2019 | $136,000 | +142.9% | 63,609 | +319.5% | 0.01% | 0.0% |
Q3 2016 | $56,000 | -18.8% | 15,163 | -50.8% | 0.01% | -55.6% |
Q2 2016 | $69,000 | +4.5% | 30,830 | -2.5% | 0.03% | +8.0% |
Q1 2016 | $66,000 | -10.8% | 31,610 | +28.7% | 0.02% | -24.2% |
Q4 2015 | $74,000 | +76.2% | 24,568 | +43.9% | 0.03% | +65.0% |
Q3 2015 | $42,000 | +2.4% | 17,068 | +50.2% | 0.02% | -25.9% |
Q1 2015 | $41,000 | – | 11,360 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |